Radiation therapy gopaul

66
Radiotherapy in the Treatment of Cancer Darin Gopaul MD FRCPC Grand River Regional Cancer Centre

Transcript of Radiation therapy gopaul

Page 1: Radiation therapy gopaul

Radiotherapy in the Treatment of Cancer

Darin Gopaul MD FRCPC

Grand River Regional Cancer Centre

Page 2: Radiation therapy gopaul

Introduction

Page 3: Radiation therapy gopaul
Page 4: Radiation therapy gopaul
Page 5: Radiation therapy gopaul

POISONED! -- as They Chatted Merrily at Their Work

Painting the Luminous Numbers on Watches, the Radium Accumulated in Their Bodies, and Without Warning Began to Bombard and Destroy Teeth, Jaws and Finger Bones. Marking Fifty Young Factory Girls for Painful, Lingering, But Inevitable Death"

Page 6: Radiation therapy gopaul

Marie Curie (1867 – 1934)

Born in Poland

University of Paris age 24

Discovered Radium 1898

t1/2 = 1602 years

Page 7: Radiation therapy gopaul

Fletcher-Suit applicator

Intracavitary

Brachytherapy

Page 8: Radiation therapy gopaul

Interstitial Brachytherapy

Radium Needles

Page 9: Radiation therapy gopaul

Prostate Brachytherapy

Page 10: Radiation therapy gopaul

Prostate Brachytherapy

Iodine 125

t ½ = 60 days

Gamma emitter

Energy 35 kV

Page 11: Radiation therapy gopaul

Free-hand implant technique

Page 12: Radiation therapy gopaul

Prostate Brachytherapy

Page 13: Radiation therapy gopaul
Page 14: Radiation therapy gopaul

Prostate Brachytherapy

Adverse effects• Urinary symptoms common

• Dysuria, frequency, urgency, nocturia

• Acute urinary retention 1-14%• Urinary incontinence 5- 6%• Proctitis 1-3%

But…• Sexual potency preserved 86 -96%

• At 2 – 3 years

Page 15: Radiation therapy gopaul

Prostate Brachytherapy

Results:

Gleason 2-4 86%

Gleason 5-6 63%

PSA < 4 93-100%

PSA 4 -10 70-86%

T1c 90-94%T2a 70-74%

5 year actuarial biochemical freedom from failure

Page 16: Radiation therapy gopaul

Prostate Brachytherapy

Patient Selection

• PSA < 10

• Gleason score 2 – 6

• T1c – T2a

Page 17: Radiation therapy gopaul

Prostate Brachytherapy

• Advantages over standard EBRT:Advantages over standard EBRT:– Does not require 6 - 7 weeks of daily fractionated treatmentsDoes not require 6 - 7 weeks of daily fractionated treatments– Less long-term toxicity due to radiation of adjacent organsLess long-term toxicity due to radiation of adjacent organs– Lower incidence of erectile dysfunctionLower incidence of erectile dysfunction– Day surgery procedure requiring only a single visitDay surgery procedure requiring only a single visit

• Disadvantages compared to EBRT:Disadvantages compared to EBRT:– More susceptible to dosimetry errors in delivery of radiationMore susceptible to dosimetry errors in delivery of radiation– Requires a general / spinal anesthetic for implantRequires a general / spinal anesthetic for implant– Higher incidence of voiding dysfunction at time and after Higher incidence of voiding dysfunction at time and after

treatmenttreatment– Requires precautions regarding radiation exposure to family Requires precautions regarding radiation exposure to family

and friendsand friends– Only proven for low-stage and low-grade diseaseOnly proven for low-stage and low-grade disease

Page 18: Radiation therapy gopaul

External Beam Radiotherapy

Page 19: Radiation therapy gopaul

1951 – First Cobalt machine

• Saskatoon, Saskatchewan

• London, Ontario

• Co 60– t ½ = 5.26 years

– Gamma emitter

– Energy 1.25 MV

Page 20: Radiation therapy gopaul

Cobalt- 60

Page 21: Radiation therapy gopaul

Definition

Gray:

A unit of absorbed radiation equal to the dose of one joule of energy absorbed per kilogram of matter, or 100 rads.

Page 22: Radiation therapy gopaul

Typical doses

Palliative therapy 8 Gy in 1 fraction

20 Gy in 5 fractions

Adjuvant therapy 42.5 Gy in 16

50 Gy in 25

Radical Doses 60 Gy in 30

78 Gy in 39

Page 23: Radiation therapy gopaul

Palliative Radiotherapy

Page 24: Radiation therapy gopaul

Palliative radiotherapy

• Relief of symptoms (bone met)

• Prevention of symptoms or morbidity

• Improve survival duration (brain mets)

Page 25: Radiation therapy gopaul

Case 1 – Palliative Radiotherapy

58 yo female with a history of metastatic breast ca. Has had increasing back pain for 6 months. Bone scan showed uptake (metastasis) at T5. No evidence of visceral mets. Pain not well controlled with narcotics (limited by side effects)

Pain reproduced on palpation of T5

Page 26: Radiation therapy gopaul

Case 1 – Palliative Radiotherapy

Treated with palliative radiotherapy from T3 – T7 inclusive with 30Gy in 10 fractions over 2 weeks.

Possible side effects:

- skin dryness

- skin erythema

- odynophagia (radiation esophagitis)

Page 27: Radiation therapy gopaul

Case 1 – Palliative Radiotherapy

Treated with palliative radiotherapy from T3 – T7 inclusive with 30Gy in 10 fractions over 2 weeks.

Possible side effects:

- skin dryness

- skin erythema

- odynophagia (radiation esophagitis)

Pain relief within 3-4 weeks

Prevention of spinal cord compression?

Page 28: Radiation therapy gopaul

Skin Care Recommendations

Prevention- Wash daily with mild, non-scented pH balanced soap- Use of hand for washing the area, pat dry- No new creams or oils in the treatment area

Treatment - Asymptomatic erythema : no treatment- Dry / itchy skin: aqueous cream (glaxal base, biafine)- Red/ burning skin: 1% hydrocotisone cream - Moist desquamation : Flamazine Cream +/- dressing

Page 29: Radiation therapy gopaul

Case 2 – Palliative Radiotherapy

59 yo male smoker presenting with SOB, cough and chest discomfort. No hemoptysis. Anorexia, fatigue and a 30 lb weight loss.

CT Chest/abdomen, CT Brain, Bone scan demonstrate 14cm lung mass invading into the mediastinum (unresectable) but no mets.

PFTs demonstrate FEV1 0.8L and DLCO 36%

Page 30: Radiation therapy gopaul

Palliative Radiotherapy – Lung Ca

• Stage III : Not a candidate for radical radiotherapy

– Poor PS

– Significant weight loss– Large tumor > 7cm– Inadequate pulmonary reserve for radical

radiotherapy

• Stage IV : metastatic

Page 31: Radiation therapy gopaul

Palliative Radiotherapy – Lung Ca

Goals

• Symptom Control– Cough– Hemoptysis– Chest Pain

• Delay intrathoracic progression– Prevent lung collapse– Prevent SVC

Aim is Quality of life not Quantity of life

Page 32: Radiation therapy gopaul

Case 3 – Palliative Radiotherapy

• 42 yo female T2N1 NSCLCa, treated with surgery. 8 months later presented with a seziure, CT scan demonstrates multiple (4 brain mets)

• Treated with Whole Brain Radiotherapy with clinical/radiologic response

Page 33: Radiation therapy gopaul

Case 3 – Palliative Radiotherapy

• 8 months post Whole Brain XRT, presents with clinical/ radiologic progression.

Options?- Steroids (no response)- Surgery (not for multiple lesions)- Radiotherapy (already treated)- Radiosurgery

Page 34: Radiation therapy gopaul

Co 60 Radiosurgery – “Gamma Knife”

Page 35: Radiation therapy gopaul

“Co 60 Radiosurgery – “Gamma Knife”

• Invented 1950’s

• 201 Cobalt sources

• Precision mounted

• 4mm – 4cm target

• Rigid Immobilization

Page 36: Radiation therapy gopaul

Gamma Knife

Page 37: Radiation therapy gopaul
Page 38: Radiation therapy gopaul

Linear Accelerator

Page 39: Radiation therapy gopaul

Linear Accelerator

• X-rays• Higher energy (4 - 18Mv)

– compared to Gamma rays (1.25 Mv)

• Higher energy means– More penetrating beam– Treat deeper tumors– Enhanced skin sparing

Page 40: Radiation therapy gopaul

Linac Radiosurgery – “X Knife”

• High energy beam

• 1 moving source

• 5mm – 4cm target

Page 41: Radiation therapy gopaul

Linac Radiosurgery – “X Knife”

Advantages

• Allows multiple fractions

• More widely available

• Linac has other uses

Page 42: Radiation therapy gopaul

Cranial Radiosurgery

Indications

• Solitary Brain Met on MRI • < 4 cm maximal dimension

• 1- 3 Recurrent post Whole Brain Rads

• Good Performance Status (KPS > 70%)

• Limited or Controlled Extracranial Disease

Page 43: Radiation therapy gopaul

Adjuvant Radiotherapy

Page 44: Radiation therapy gopaul

Definition

Adjuvant Therapy:

Post-operative treatment in the absence of demonstrable residual disease, to reduce the possibility of recurrence.

Page 45: Radiation therapy gopaul

Adjuvant radiotherapy – Breast cancer

• Breast conservation

• Post mastectomy (loco-regional)

Page 46: Radiation therapy gopaul

Breast Conservation

• No difference in OS

• LR uncommon post adjuvant XRT

• LR can be salvaged with further surgery

BCS + Radiotherapy = Mastectomy

Page 47: Radiation therapy gopaul

Breast Tangents

Computer assisted radiation planning

Page 48: Radiation therapy gopaul

Adjuvant radiotherapy – Breast cancer

Reducing treatment duration (OCOG study)

• 42.5 Gy in 16 vs 50 Gy in 25

• No difference in LR control

• No difference in cosmesis

Page 49: Radiation therapy gopaul

Adjuvant radiotherapy – Breast cancer

42.5 Gy in 16 fractions now standard

• Not for very large Breast volumes

• 3-5 “boost” treatments to the tumor bed • Close or focal positive margins• Premenopausal status

Page 50: Radiation therapy gopaul

Postmastectomy Radiotherapy

Standard for High Risk disease

• Tumor > 5cm (T3)

• Tumor involves skin or chest wall (T4)

• 4 or more lymph nodes

– LRR 25-30% postmastectomy– LRR 5- 10% post Locoregional radiotherapy– OS improves 5%

Page 51: Radiation therapy gopaul

Postmastectomy Radiotherapy

Intermediate Risk disease– T2 tumor with multiple adverse features

– High grade, LVI+, ER-

– 1-3 lymph nodes– Age < 45 years

– LRR 10 -18% postmastectomy– LRR 5% post Locoregional radiotherapy

Page 52: Radiation therapy gopaul

3D Conformal Radiotherapy

Page 53: Radiation therapy gopaul

3D Conformal Radiotherapy

• Acquire 3D spacial data

• Radiation Planning in 3D

• Deliver Radiation in 3D

Page 54: Radiation therapy gopaul

Couch

CT Simulator

Page 55: Radiation therapy gopaul

MRI-CT Fusion (Co-Registration)

MRIExcellent soft tissue

contrast allows better differentiation between normal tissues and many tumors

Disadvantages: Susceptible to spatial

distortions

Page 56: Radiation therapy gopaul

Treatment Planning

Beam Placement

Page 57: Radiation therapy gopaul

Multileaf Collimator (MLC)

No more lead blocks!

Page 58: Radiation therapy gopaul

Prostate Radiotherapy

Page 59: Radiation therapy gopaul

Prostate 3D Planning

Page 60: Radiation therapy gopaul

Shaping the beam with MLC - prostate

Beam’s Eye View (BEV)Beam’s Eye View (BEV)

AP View Lateral View

Page 61: Radiation therapy gopaul

Verification - EPID images

Page 62: Radiation therapy gopaul

Increasing Conformality

Page 63: Radiation therapy gopaul

Advantages

• Enhanced Normal Tissue Sparing • Reduces side effects

• Dose Escalation Improves Cure Rate

• Higher Dose per Fraction • Reduce Number of fractions• Reduce Treatment Duration

Page 64: Radiation therapy gopaul

The Future

Page 65: Radiation therapy gopaul

Synchrony™

camera Linearaccelerator

Manipulator

Imagedetectors

X-ray sourcesTargeting System

Robotic Delivery System

Page 66: Radiation therapy gopaul

Thank-you!